Results 141 to 150 of about 3,249 (159)
Advances in therapeutic oligonucleotide conjugates. [PDF]
Zheng YY, Xue Y, Hou X, Dong Y.
europepmc +1 more source
A "metabolic dual-clamp" strategy for glucose metabolism blockade and cascade-amplified tumor immunotherapy. [PDF]
Chang P +12 more
europepmc +1 more source
International audienceG-rich oligonucleotide, AS1411, has been shown to interact with nucleolin and to inhibit cancer cell proliferation and tumor growth.
Masoud Ayatollahi Mehrgardi +2 more
exaly +2 more sources
AS1411 is a nucleolin-binding aptamer which attracted great interest as active targeting ligand for the selective delivery of therapeutic agents to tumour cells.
Daniela Montesarchio +2 more
exaly +2 more sources
Herein, one multifunctional AS1411-functionalized fluorescent gold nanoparticles (named NAANPs) is synthesized and successfully applied for both targeted cancer cell imaging and efficient photodynamic therapy (PDT).
Dan Li, Jun Ai, Baohua Lou
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Therapeutic Applications of AS1411 Aptamer, an Update Review
International Journal of Biological Macromolecules, 2020Mohammad Ramezani +2 more
exaly
Aptamer Imaging With Cu-64 Labeled AS1411: Preliminary Assessment in Lung Cancer
Nuclear Medicine and Biology, 2014Chin K Ng, John O Trent, Huaiyu Zheng
exaly
G-Quadruplex Oligonucleotide AS1411 as a Cancer-Targeting Agent: Uses and Mechanisms
Biochimica Et Biophysica Acta - General Subjects, 2017Martin G O'Toole +2 more
exaly

